Colon cancer dysplasia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with inflammatory bowel disease for more than 8 years. Patients older than 18 year.
Exclusion criteria
Exclusion criteria: Personal history of (partial) colectomy. Contraindications for the use of intravenous fluorescein ( allergy, pregnancy or breastfeeding, sever cardiopulmonary disease or renal failure). Currently known colonic neoplasia (e.g. referred patient or patients who refused treatment of neoplasia in the past). Non-correctable coagulopathy that precludes taking biopsies (international normalized ratio >2 or platelet count
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare endoscopic trimodal imaging (ETMI) vs. chromoendoscopy-guided confocal laser endomicroscopy (CCLE) for differentiating neoplastic from non-neoplastic mucosa in patients with ulcerative colitis (UC). | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Compare neoplasia detection rates of autofluorescence imaging (AFI) vs. chromoendoscopy (CE) and (2) identify diagnostic endoscopic markers for differentiation between dysplasia associated lesions/masses (DALMs) and adenoma-like masses (ALMs) | — |
Countries
Netherlands